1-20 of 28
Hongmei Jing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide Versus Thalidomide or Bortezomib As Maintenance Regimens for Non-Transplant Patients with Multiple Myeloma: Multi-Center Real World Experience in China

Zhe Zhuang, Lei Shi, Ying Tian, Dongmei Zou, Ru Feng, Fei Dong, Yanping Ma, Hong Yu, Wei-wei Tian, Shuangjiao Liu, Liangming Ma, Rong Fu, Hongmei Jing, Hui Liu, Wanling Sun, Chen Wenming, Yin Wu, Li Bao, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4728.
DOI: https://doi.org/10.1182/blood-2021-149502
Published: 2021
Journal Articles

Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimens for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China

Zhe Zhuang, Ying Tian, Wei-wei Tian, Hong Yu, Dongmei Zou, Qinhua Liu, Lei Shi, Fei Dong, Yanping Ma, Ru Feng, Shuangjiao Liu, Hui Liu, Hongmei Jing, Li Bao, Wanling Sun, Rong Fu, Liangming Ma, Chen Wenming, Yin Wu, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4766.
DOI: https://doi.org/10.1182/blood-2021-152542
Published: 2021
Journal Articles

Phase 2 March Study: ATG-010 Plus Low Dose Dexamethasone in Chinese Relapsed/Refractory Multiple Myeloma (RRMM) Patients Previously Treated with an Immunomodulatory Agent (IMiD) and a Proteasome Inhibitor (PI)

Lugui Qiu, Weijun Fu, Zhongjun Xia, Zhengzheng Fu, Wenming Chen, Chunkang Chang, Baijun Fang, Gang An, Yongqiang Wei, Zhen Cai, Sujun Gao, Jianyu Weng, Lijuan Chen, Hongmei Jing, Li Fei, Zhuogang Liu, Xiequn Chen, Jing Liu, Yang Yu, Aihua Wang, Yijun Yang, Zhinuan Yu, Kevin Lynch
Journal: Blood
Blood (2021) 138 (Supplement 1): 4770.
DOI: https://doi.org/10.1182/blood-2021-145282
Published: 2021
Journal Articles

ATG-010 Plus Low-Dose Dexamethasone (Sd) in Chinese Relapsed/Refractory Multiple Myeloma (RRMM) Patients Previously Received Chimeric Antigen Receptor T-Cell (CAR-T)

Weijun Fu, Lugui Qiu, Zhongjun Xia, Zhengzheng Fu, Wenming Chen, Chunkang Chang, Baijun Fang, Gang An, Yongqiang Wei, Zhen Cai, Sujun Gao, Jianyu Weng, Lijuan Chen, Hongmei Jing, Li Fei, Zhuogang Liu, Xiequn Chen, Jing Liu, Yang Yu, Aihua Wang, Zhinuan Yu, Yijun Yang, Kevin Lynch
Journal: Blood
Blood (2021) 138 (Supplement 1): 4778.
DOI: https://doi.org/10.1182/blood-2021-146784
Published: 2021
Journal Articles

Trial in Progress: A Perspective Study of Pan-Oral Triplet Regimen Pomalidomide, Ixazomib and Dexamethasone in Relapsed or Refractory Myeloma Patients

Miao Chen, Li Bao, Wenming Chen, Rong Fu, Rong Guo, Hongmei Jing, Hui Liu, Qinhua Liu, Yanping Ma, Xiuli SUN, Wei Wang, Yafei Wang, Xiaojing Yan, Jiang Qian, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4783.
DOI: https://doi.org/10.1182/blood-2021-148237
Published: 2021
Journal Articles

Clinical Characteristics, Treatment and Outcome of Patients with Mantle Cell Lymphoma: A Large, Multicenter Retrospective Analysis in China

Ping Yang, Shuozi Liu, Jing Wang, Wei Zhang, Hui Liu, Xiuhua Sun, Yujun Dong, Hongmei Jing
Journal: Blood
Blood (2021) 138 (Supplement 1): 4522.
DOI: https://doi.org/10.1182/blood-2021-149042
Published: 2021
Journal Articles

Follicular Lymphoma Grade 3A Is Different from Grade 1/2 in the Real World

Chunyuan Li, Ping Yang, Wei Wan, Shuozi Liu, Hongmei Jing
Journal: Blood
Blood (2021) 138 (Supplement 1): 4524.
DOI: https://doi.org/10.1182/blood-2021-148271
Published: 2021
Journal Articles

Clinical and Molecular Biology Analysis of Patients with Mantle Cell Lymphoma Resistant to BTK Inhibitor

Lingli Wang, Ping Yang, Weilong Zhang, Jing Wang, Hongmei Jing
Journal: Blood
Blood (2021) 138 (Supplement 1): 4527.
DOI: https://doi.org/10.1182/blood-2021-149114
Published: 2021
Journal Articles

XPO1 Inhibitor (ATG-010) Plus Chemotherapy per Investigator's Choice for Heavily Pretreated Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Extranodal NK/T-Cell Lymphoma (ENKTL)：Preliminary Results from a Multicenter, Single-Arm, Phase Ib Study (TOUCH Trial)

Huiqiang Huang, Yan Gao, Huilai Zhang, Keshu Zhou, Jianqiu Wu, Zhen Cai, Hongmei Jing, Lei Fan, Sai Lou, Yizhou Fei, Aihua Wang, Kevin Lynch
Journal: Blood
Blood (2021) 138 (Supplement 1): 2452.
DOI: https://doi.org/10.1182/blood-2021-147100
Published: 2021
Journal Articles

Efficacy and Safety of PD-1 Inhibitor Plus Rituximab in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Yan Qin, Xiaohui He, Sheng Yang, Peng Liu, Shengyu Zhou, Jianliang Yang, Lin Gui, Qiaofeng Zhong, Fengyi Zhao, Yuankai Shi, Hongmei Jing, Shiyue Zhang, Ruihan Guo, Yuankai Shi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2485.
DOI: https://doi.org/10.1182/blood-2021-152094
Published: 2021
Journal Articles

Next-Generation Sequencing Reveals Molecular Heterogeneity in Primary Testicular DLBCL

Shuozi Liu, Ping Yang, Jing Wang, Weilong Zhang, Hongmei Jing
Journal: Blood
Blood (2021) 138 (Supplement 1): 1426.
DOI: https://doi.org/10.1182/blood-2021-149039
Published: 2021
Journal Articles

Development and Validation of a Novel Prognostic Nomogram Model and a Web-Based Survival Rate Calculator for Diffuse Large B-Cell Lymphoma in the Rituximab Era

Qiaofeng Zhong, Haizhu Chen, Yan Qin, Xiaohui He, Sheng Yang, Shengyu Zhou, Peng Liu, Yuankai Shi, Hongmei Jing
Journal: Blood
Blood (2021) 138 (Supplement 1): 1450.
DOI: https://doi.org/10.1182/blood-2021-154210
Published: 2021
Journal Articles

The Type II Glycoengineered Humanized Anti-CD20 Monoclonal Antibody MIL62 Combined with Lenalidomide in Chinese Patients with Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma: Results of a Multicenter, Single-Arm, Phase 1b/2 Trial

Yuankai Shi, Yan Qin, Yongping Song, Keshu Zhou, Hui Zhou, Hongmei Jing, Ying Xiang, Zhao Wang, Zhen Wang, Aimin Zang, Ou Bai, Zhenyu Li, Huilai Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1351.
DOI: https://doi.org/10.1182/blood-2021-146440
Published: 2021
Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Prospective, Single-Arm, Open-Label, Multi-Center, Phase Ⅱ Clinical Trial

Yan Gao, MD PhD, Huiqiang Huang, MDPhD, Xiaoxiao Wang, Bing Bai, Yunhong Huang, MD PhD, Haiyan Yang, MD PhD, QingYuan Zhang, MD, Yufu Li, Yan Li, Min Zhou, PhD, Runxiang Yang, Bing Xu, Lihong Liu, MD, Yu Yang, MD PhD, Zhigang Peng, Ding Yu, Hui Zhou, MD PhD, Rong yan Zhang, Huilai Zhang, MD PhD, Junyuan Qi, MD, Yaming Xi, Xiaojing Xing, Zhao Wang, MD, Hongmei Jing, Xiaohong Zhang, Liping Ma, Hongyan Jin, Hongxia Yao, PhD, Yuerong Shuang, Xuefang Xia, Jianfei Xue, Chunlei Li
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
DOI: https://doi.org/10.1182/blood-2020-141752
Published: 2020
Journal Articles

B7-H6 Is Associated with Poor Prognosis and a Potential Therapeutic Target of T-Lymphoblastic Lymphoma

Lei Yuan, Lu Sun, Yu Zhao, Hongmei Jing, MD PhD, Xiaoyan Ke, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33.
DOI: https://doi.org/10.1182/blood-2020-139146
Published: 2020
Journal Articles

Efficacy and Safety Analysis of Ibrutinib-Containing Therapy for Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from a Real-World Study in China

Qingqing Cai, PhD, Huiqiang Huang, MDPhD, Yuchen Zhang, Panpan Liu, MD PhD, Hongmei Jing, MD PhD, Ping Yang, MD PhD, Tongyu Lin, MD PhD, Zhongjun Xia, MDPhD, Zhiming Li, MD PhD, Wenyu Li, PhD, Liye Zhong, MD PhD, Xu Ye, MD PhD, Xueli Jin, MD PhD, Liling Zhang, MD PhD, Huilai Zhang, MD PhD, Xiuhua Sun, MD, Yuyang Tian, MM, Shuyun Ma, MM, Ning Su, MM, Jun Cai, BMBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
DOI: https://doi.org/10.1182/blood-2020-136842
Published: 2020
Journal Articles

Waldenström's Macroglobulinaemia in the Modern Era: Real World Outcomes and Prognostication across 35 Chinese Academic Hospitals

Xin-xin Cao, MD, Shuhua Yi, MD, Zhongxing Jiang, MD, Jingsong He, MD, Wei Yang, Juan Du, Jr., MD, Chunyan Sun, MD PhD, Yu Wu, MD, Chen Wenming, MD, Xiao-jun Liu, Bingzong Li, MDPhD, Chunrui Li, MDPhD, Wei Sang, Qin-hua Liu, Xiaoxia Chu, Li Fei, Ou Bai, Min Mao, Rong Fu, PhD, Wei WANG, MD, Lihong Liu, MD, Luqun Wang, MDPhD, Yujun Dong, MD, Jun Luo, DO, Zhenling Li, Yongqiang Wei, Qi-ke Zhang, Jing Liu, Kaiyang Ding, Liang Zou, Bi-yun Chen, Luoming Hua, PhD, Hongmei Jing, Juan He, PhD, Liang Wang, Lugui Qiu, MD, Jian Li, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
DOI: https://doi.org/10.1182/blood-2020-134785
Published: 2020
Journal Articles

Long-Term Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study

Yuqin Song, MD PhD, Yongping Song, MD, Lihong Liu, MD, Mingzhi Zhang, MD, Zhiming Li, MD PhD, Chunyan Ji, MD, Wei Xu, MD PhD, Ting Liu, MD PhD, Bing Xu, MD PhD, Xin Wang, MDPhD, Sujun Gao, Huilai Zhang, MD PhD, Yu Hu, MD, Yan Li, Ying Cheng, Haiyan Yang, MD PhD, Junning Cao, Zunmin Zhu, MD, Jianda Hu, MDPhD, Wei Zhang, Hongmei Jing, MD PhD, Kaiyang Ding, Zhengguang Lu, Bin Zhang, PhD, Renbin Zhao, PhD, Zhixin Xu, MD PhD, Jun Zhu, BS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
DOI: https://doi.org/10.1182/blood-2020-141781
Published: 2020
Journal Articles

Yf-H-2015005, a New CXCR4 Antagonist, in the Mobilization of Hematopoietic Stem Cells in Patients with Non-Hodgkin Lymphoma: A Randomized-Controlled Phase 3 Study

Weiping Liu, Yufu Li, Quanshun Wang, Kaiyang Ding, Hang Su, Yue-rong Shuang, Sujun Gao, Hongmei Jing, Ye Chai, Dehui Zou, Hui Liu, Chunling Wang, Lihong LIU, Yicheng Zhang, Jinying Lin, Haiyan Zhu, Meixia Shang, Xiaoyan Yan, Chen Yao, Fengyuan Chang, Jun Zhu, MD, Yuqing Song
Journal: Blood
Blood (2019) 134 (Supplement_1): 590.
DOI: https://doi.org/10.1182/blood-2019-125456
Published: 2019
Journal Articles

Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study

Yuqin Song, MD PhD, Yongping Song, MD, Lihong Liu, Mingzhi Zhang, Zhiming Li, Chunyan Ji, Wei Xu, MD PhD, Ting Liu, MD, Bing Xu, Xin Wang, MD PhD, Sujun Gao, Huilai Zhang, MD, Yu Hu, Yan Li, Ying Cheng, Haiyan Yang, Junning Cao, MD, Zunmin Zhu, Jianda Hu, PhD, Wei Zhang, Hongmei Jing, Kaiyang Ding, Zhengguang Lu, Bin Zhang, PhD, Renbin Zhao, Zhixin Xu, Jun Zhu, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 755.
DOI: https://doi.org/10.1182/blood-2019-126305
Published: 2019